The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability

Cellular and Molecular Life Sciences

Volumn 74, Issue 1, 2017, Pages 23-38

  Meng, Xin ^a   Clews, Jack ^a   Kargas, Vasileios ^a   Wang, Xiaomeng ^a   Ford, Robert C ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Biological detergent; CFTR; Cystic fibrosis; Membrane protein stability; Membrane protein structure

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ION TRANSPORT AFFECTING AGENT; IVACAFTOR; LUMACAFTOR; TEZACAFTOR; UNCLASSIFIED DRUG; VX 152; VX 440;

BIOACCUMULATION; CARBOXY TERMINAL SEQUENCE; CONFORMATION; CYSTIC FIBROSIS; FLUORESCENCE ANALYSIS; GENE DELETION; HUMAN; MOLECULAR DYNAMICS; MOLECULAR MODEL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; REVIEW; STRUCTURE ACTIVITY RELATION; THERMOSTABILITY; ANIMAL; CHEMISTRY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; PROTEIN CONFORMATION;

ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HUMANS; PROTEIN CONFORMATION; PROTEIN STABILITY; SEQUENCE DELETION;

EID: 84991067900     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-016-2386-8     Document Type: Review

References (92)

1. Mikhailov MV, Campbell JD, de Wet H et al (2005) 3-D structural and functional characterization of the purified KATP channel complex Kir6.2-SUR1. EMBO J 24:4166–4175
2. Bryan J, Aguilar-Bryan L (1999) Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K(+) channels. Biochim Biophys Acta 1461:285–303
3. Bozoky Z, Krzeminski M, Muhandiram R et al (2013) Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions. Proc Natl Acad Sci USA 110:E4427–E4436
4. Ostedgaard LS, Baldursson O, Welsh MJ (2001) Regulation of the cystic fibrosis transmembrane conductance regulator Cl-channel by its R domain. J Biol Chem 276:7689–7692
5. Wang Y, Wrennal J, Cai Z et al (2014) Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models. Int J Biochem Cell Biol 52:47–57
6. Vergani P, Lockless SW, Nairn AC et al (2005) CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433:876–880
7. Bozoky Z, Krzeminski M, Muhandiram R et al (2013) Regulatory R region of the CFTR chloride channel is a dynamic integrator of phospho-dependent intra- and intermolecular interactions. Proc Natl Acad Sci USA 110:E4427–E4436
8. Ratjen F, Döring G (2003) Cystic fibrosis. Lancet 361:681–689
9. Goodman B, Percy W (2005) CFTR in cystic fibrosis and cholera: from membrane transport to clinical practice. AJP Adv Physiol Educ 29:75–82
10. Van Goor F, Hadida S, Grootenhuis PDJ et al (2011) Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci USA 108:18843–18848
11. Molinski S, Eckford PD, Pasyk S et al (2012) Functional rescue of F508del-CFTR using small molecule correctors. Front Pharmacol 3:160
12. He LH, Aleksandrov AA, An JL et al (2015) Restoration of NBD1 thermal stability is necessary and sufficient to correct delta F508 CFTR folding and assembly. J Mol Biol 427:106–120
13. Farinha CM, Matos P (2016) Repairing the basic defect in cystic fibrosis—one approach is not enough. FEBS J 283:246–264
14. Riordan JR (2008) CFTR function and prospects for therapy. Annu Rev Biochem 77:701–726
15. Serohijos AW, Hegedus T, Aleksandrov AA et al (2008) Phenylalanine-508 mediates a cytoplasmic-membrane domain contact in the CFTR 3D structure crucial to assembly and channel function. Proc Natl Acad Sci USA 105:3256–3261
16. He L, Kota P, Aleksandrov AA et al (2013) Correctors of DeltaF508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein. FASEB J Off Publ Fed Am Soc Exp Biol 27:536–545
17. He L, Aleksandrov AA, Serohijos AW et al (2008) Multiple membrane-cytoplasmic domain contacts in the cystic fibrosis transmembrane conductance regulator (CFTR) mediate regulation of channel gating. J Biol Chem 283:26383–26390
18. Ward CL, Omura S, Kopito RR (1995) Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83:121–127
19. Kopito RR (1999) Biosynthesis and degradation of CFTR. Physiol Rev 79:S167–S173
20. Grove DE, Rosser MFN, Watkins RL et al (2011) Analysis of CFTR folding and degradation in transiently transfected cells. Cys Fibros Diagn Protoc Vol I Approaches Study Correct CFTR Defects 741:219–232
21. Cui L, Aleksandrov L, Chang XB et al (2007) Domain interdependence in the biosynthetic assembly of CFTR. J Mol Biol 365:981–994
22. Dalemans W, Barbry P, Champigny G et al (1991) Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation. Nature 354:526–528
23. Denning GM, Anderson MP, Amara JF et al (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761–764
24. Sato S, Ward CL, Krouse ME et al (1996) Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 271:635–638
25. Pedemonte N, Galietta LJ (2012) Pharmacological correctors of mutant CFTR mistrafficking. Front Pharmacol 3:175
26. Eckford PD, Bear CE (2011) Targeting the regulation of CFTR channels. Biochem J 435:e1–e4
27. Meacham GC, Patterson C, Zhang WY et al (2001) The Hsc70 co-chaperone CHIP targets immature CFTR for proteasomal degradation. Nat Cell Biol 3:100–105
28. Becq F, Mettey Y, Gray MA et al (1999) Development of substituted benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel. J Biol Chem 274:27415–27425
29. Dormer RL, Dérand R, McNeilly CM et al (2001) Correction of delF508-CFTR activity with benzo(c)quinolizinium compounds through facilitation of its processing in cystic fibrosis airway cells. J Cell Sci 114:4073–4081
30. Pedemonte N, Lukacs GL, Du K et al (2005) Small-molecule correctors of defective deltaF508-CFTR cellular processing identified by high-throughput screening. J Clin Investig 115:2564–2571
31. Hutt DM, Herman D, Rodrigues AP et al (2009) Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat Chem Biol 6:25–33
32. Pedemonte N, Tomati V, Sondo E et al (2011) Dual activity of aminoarylthiazoles on the trafficking and gating defects of the cystic fibrosis transmembrane conductance regulator chloride channel caused by cystic fibrosis mutations. J Biol Chem 286:15215–15226
33. Van Goor F, Straley KS, Cao D et al (2006) Rescue of deltaF508-CFTR trafficking and gating in human cystic fibrosis airway primary cultures by small molecules. Am J Physiol Lung Cell Mol Physiol 290:L1117–L1130
34. Van Goor F, Hadida S, Grootenhuis PD et al (2011) Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci USA 108:18843–18848
35. Haq IJ, Gray MA, Garnett JP et al (2015) Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets. Thorax 71:284–287
36. Clancy JP, Rowe SM, Accurso FJ et al (2012) Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation. Thorax 67:12–18
37. Farinha CM, Sousa M, Canato S et al (2015) Increased efficacy of VX-809 in different cellular systems results from an early stabilization effect of F508del-CFTR. Pharmacol Res Perspect 3:e00152
38. Sampson HM, Robert R, Liao J et al (2011) Identification of a NBD1-binding pharmacological chaperone that corrects the trafficking defect of F508del-CFTR. Chem Biol 18:231–242
39. Veit G, Avramescu RG, Perdomo D et al (2014) Some gating potentiators, including VX-770, diminish deltaF508-CFTR functional expression. Sci Transl Med 6:246ra297
40. Cholon DM, Quinney NL, Fulcher ML et al (2014) Potentiator ivacaftor abrogates pharmacological correction of deltaF508 CFTR in cystic fibrosis. Sci Transl Med 6:246ra296
41. Osmanbeyoglu HU, Wehner JA, Carbonell JG et al (2010) Active machine learning for transmembrane helix prediction. BMC Bioinform 11(Suppl 1):S58
42. Zhang Z, Kuipers G, Niemiec L et al (2015) High-level production of membrane proteins in E. coli BL21(DE3) by omitting the inducer IPTG. Microb Cell Factories 14:142
43. Whittaker MM, Whittaker JW (2014) Expression and purification of recombinant Saccharomyces cerevisiae mitochondrial carrier protein YGR257Cp (Mtm1p). Protein Expr Purif 93:77–86
44. Lundstrom K, Wagner R, Reinhart C et al (2006) Structural genomics on membrane proteins: comparison of more than 100 GPCRs in 3 expression systems. J Struct Funct Genomics 7:77–91
45. Garavito RM, Picot D, Loll PJ (1996) Strategies for crystallizing membrane proteins. J Bioenerg Biomembr 28:13–27
46. Seddon AM, Curnow P, Booth PJ (2004) Membrane proteins, lipids and detergents: not just a soap opera. Biochim Biophys Acta 1666:105–117
47. Linke D (2009) Detergents: an overview. Methods Enzymol 463:603–617
48. Krueger-Koplin RD, Sorgen PL, Krueger-Koplin ST et al (2004) An evaluation of detergents for NMR structural studies of membrane proteins. J Biomol NMR 28:43–57
49. Fethiere J (2007) Three-dimensional crystallization of membrane proteins. Methods Mol Biol 363:191–223
50. Kim JM, Wu SP, Tomasiak TM et al (2015) Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter. Nature 517:U396–U598
51. Pollock NL, Satriano L, Zegarra-Moran O et al (2016) Structure of wild type and mutant F508del CFTR. A small-angle X-ray scattering study of the protein-detergent complexes. J Struct Biol 194:102–111
52. Le Brun AP, Clifton LA, Holt SA et al (2016) Deuterium labeling strategies for creating contrast in structure-function studies of model bacterial outer membranes using neutron reflectometry. Methods Enzymol 566:231–252
53. Yang ZR, Wang C, Zhou QX et al (2014) Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains. Protein Sci 23:769–789
54. Aleksandrov LA, Jensen TJ, Cui LY et al (2015) Thermal stability of purified and reconstituted CFTR in a locked open channel conformation. Protein Expr Purif 116:159–166
55. Geertsma ER, Groeneveld M, Slotboom DJ et al (2008) Quality control of overexpressed membrane proteins. Proc Natl Acad Sci USA 105:5722–5727
56. Hattori M, Hibbs RE, Gouaux E (2012) A fluorescence-detection size-exclusion chromatography-based thermostability assay for membrane protein precrystallization screening. Structure 20:1293–1299
57. Oldham ML, Hite RK, Steffen AM et al (2016) A mechanism of viral immune evasion revealed by cryo-EM analysis of the TAP transporter. Nature 529:537–540
58. Bai XC, Yan CY, Yang GH et al (2015) An atomic structure of human gamma-secretase. Nature 525:212–217
59. Nogales E, Scheres SHW (2015) Cryo-EM: a unique tool for the visualization of macromolecular complexity. Mol Cell 58:677–689
60. Zhou HX, Cross TA (2013) Influences of membrane mimetic environments on membrane protein structures. Annu Rev Biophys 42:361–392
61. Tate CG (2012) A crystal clear solution for determining G-protein-coupled receptor structures. Trends Biochem Sci 37:343–352
62. Moon CP, Fleming KG (2011) Using tryptophan fluorescence to measure the stability of membrane proteins folded in liposomes. Methods Enzymol 492:189–211
63. Kohlstaedt M, von der Hocht I, Hilbers F et al (2015) Development of a Thermofluor assay for stability determination of membrane proteins using the Na(+)/H(+) antiporter NhaA and cytochrome c oxidase. Acta Crystallogr D Biol Crystallogr 71:1112–1122
64. Huang P, Liu Q, Scarborough GA (1998) Lysophosphatidylglycerol: a novel effective detergent for solubilizing and purifying the cystic fibrosis transmembrane conductance regulator. Anal Biochem 259:89–97
65. Huang P, Stroffekova K, Cuppoletti J et al (1996) Functional expression of the cystic fibrosis transmembrane conductance regulator in yeast. Biochim Biophys Acta 1281:80–90
66. O’ryan L, Rimington T, Cant N et al (2012) Expression and purification of the cystic fibrosis transmembrane conductance regulator protein in Saccharomyces cerevisiae. Jove J Vis Exp 61:e3860
67. Pollock N, Cant N, Rimington T et al (2014) Purification of the cystic fibrosis transmembrane conductance regulator protein expressed in Saccharomyces cerevisiae. J Vis Exp (87):51447. doi:10.3791/51447
68. Yang Z, Wang C, Zhou Q et al (2014) Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains. Protein Sci Publ Protein Soc 23:769–789
69. Zhang L, Aleksandrov LA, Zhao Z et al (2009) Architecture of the cystic fibrosis transmembrane conductance regulator protein and structural changes associated with phosphorylation and nucleotide binding. J Struct Biol 167:242–251
70. Huang P, Liu Q, Scarborough GA (1998) Lysophosphatidylglycerol: a novel effective detergent for solubilizing and purifying the cystic fibrosis transmembrane conductance regulator. Anal Biochem 259:89–97
71. Newstead S, Kim H, von Heijne G et al (2007) High-throughput fluorescent-based optimization of eukaryotic membrane protein overexpression and purification in Saccharomyces cerevisiae. Proc Natl Acad Sci USA 104:13936–13941
72. Newstead S, Ferrandon S, Iwata S (2008) Rationalizing alpha-helical membrane protein crystallization. Protein Sci 17:466–472
73. Vogel R, Fan GB, Sheves M et al (2001) Salt dependence of the formation and stability of the signaling state in G protein-coupled receptors: evidence for the involvement of the Hofmeister effect. Biochemistry 40:483–493
74. Gekko K, Timasheff SN (1981) Thermodynamic and kinetic examination of protein stabilization by glycerol. Biochemistry 20:4677–4686
75. Rubinstein JL (2007) Structural analysis of membrane protein complexes by single particle electron microscopy. Methods 41:409–416
76. Ramjeesingh M, Li C, Garami E et al (1997) A novel procedure for the efficient purification of the cystic fibrosis transmembrane conductance regulator (CFTR). Biochem J 327(Pt 1):17–21
77. Yang Z, Wang C, Zhou Q et al (2014) Membrane protein stability can be compromised by detergent interactions with the extramembranous soluble domains. Protein Sci 23:769–789
78. Accurso FJ, Rowe SM, Clancy JP et al (2010) Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med 363:1991–2003
79. Ramsey BW, Davies J, McElvaney NG et al (2011) A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 365:1663–1672
80. Van Goor F, Hadida S, Grootenhuis PD et al (2009) Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci USA 106:18825–18830
81. Yu H, Burton B, Huang CJ et al (2012) Ivacaftor potentiation of multiple CFTR channels with gating mutations. J Cyst Fibros 11:237–245
82. Eckford PD, Li C, Ramjeesingh M et al (2012) Cystic fibrosis transmembrane conductance regulator (CFTR) potentiator VX-770 (ivacaftor) opens the defective channel gate of mutant CFTR in a phosphorylation-dependent but ATP-independent manner. J Biol Chem 287:36639–36649
83. Carmelo V, Bogaerts P, Sa-Correia I (1996) Activity of plasma membrane H+-ATPase and expression of PMA1 and PMA2 genes in Saccharomyces cerevisiae cells grown at optimal and low pH. Arch Microbiol 166:315–320
84. Schultz BD, Bridges RJ, Frizzell RA (1996) Lack of conventional ATPase properties in CFTR chloride channel gating. J Membr Biol 151:63–75
85. Al-Zahrani A, Cant N, Kargas V, Rimington T, Aleksandrov L, Riordan JR, Ford RC (2015) Structure of the cystic fibrosis transmembrane conductance regulator in the inward-facing conformation revealed by single particle electron microscopy. AIMS Biophys 2:131–152
86. Lee SC, Bennett BC, Hong WX et al (2013) Steroid-based facial amphiphiles for stabilization and crystallization of membrane proteins. Proc Natl Acad Sci USA 110:E1203–E1211
87. Sonoda Y, Newstead S, Hu NJ et al (2011) Benchmarking membrane protein detergent stability for improving throughput of high-resolution X-ray structures. Structure 19:17–25
88. Alexandrov AI, Mileni M, Chien EY et al (2008) Microscale fluorescent thermal stability assay for membrane proteins. Structure 16:351–359
89. Ayers FC, Warner GL, Smith KL et al (1986) Fluorometric quantitation of cellular and nonprotein thiols. Anal Biochem 154:186–193
90. Mornon JP, Lehn P, Callebaut I (2008) Atomic model of human cystic fibrosis transmembrane conductance regulator: membrane-spanning domains and coupling interfaces. Cell Mol Life Sci 65:2594–2612
91. Mornon JP, Lehn P, Callebaut I (2009) Molecular models of the open and closed states of the whole human CFTR protein. Cell Mol Life Sci CMLS 66:3469–3486
92. Protasevich I, Yang Z, Wang C et al (2010) Thermal unfolding studies show the disease causing F508del mutation in CFTR thermodynamically destabilizes nucleotide-binding domain 1. Protein Sci Publ Protein Soc 19:1917–1931